What do bolus, fanning and linear filler-technique terms actually describe?

Bolus, linear threading, serial puncture and fanning describe ways product may be deposited in tissue; none is a certificate of safety or a natural result. Risk depends on anatomy, plane, product, instrument, volume, pressure, speed and emergency readiness working together.

This translation has no recorded clinical or medical-language review.

Direct answer

Different injectors may use the same technique name with different planes, volumes and instruments.
A method used in one region may be unsuitable or outside labeling in another.
A technique label is not a mechanism that removes intravascular injection risk.

What the terms describe

A bolus may describe a defined deposit at one point; linear threading places product along a track; fanning uses multiple tracks from one entry; serial puncture uses separate small deposits. These broad labels do not reveal needle versus cannula, force at the tip, true anatomical plane or volume per deposit. Without those details, papers and marketing demonstrations cannot be meaningfully compared.

Why safety is wider than a technique name

Vascular courses vary, and a moving tip can cross tissue planes. Product rheology, needle diameter, injection pressure and existing scar or filler also affect distribution. Slow delivery or a cannula may change components of risk; neither makes vascular occlusion impossible. Current product instructions, training and region-specific anatomy must be considered together.

What belongs in the patient record

The record should not say only 'fanning technique'. Document product and lot, total and regional volume, needle or cannula type, entry sites, intended plane, important observations and injector. Explain limits, alternatives and early vascular symptoms rather than using technical vocabulary to promise superiority. If the plan changes during treatment, record the reason and revised approach.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
BELOTERO VOLUME (+) Lidocaine — Instructions for Use
FDA device labeling / Merz North America · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Use of Ultrasound in the Management of Hyaluronic Acid Filler Complications: An International Delphi Consensus
International expert Delphi panel · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review